已收盤 02-06 16:00:00 美东时间
-0.115
-1.04%
今日重点评级关注:Piper Sandler:上调Korro Bio评级至"超配",目标价从11美元升至30美元;Piper Sandler:维持Nurix Therapeutics"超配"评级,目标价从32美元升至35美元
01-30 17:38
Barrington Research analyst Kevin Steinke maintains HireQuest (NASDAQ:HQI) with a Outperform and maintains $13 price target.
01-30 04:31
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从12美元升至15美元;Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至107美元
2025-11-13 09:58
Barrington Research analyst Kevin Steinke maintains HireQuest (NASDAQ:HQI) with a Outperform and maintains $13 price target.
2025-11-13 03:56
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据HireQuest 2025年第三季度业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** 总营收为850万美元,同比下降9.8%(去年同期940万美元)。其中特许经营权使用费收入810万美元(去年同期900万美元),服务收入38.7万美元(去年同期42.8万美元)。 **盈利能力:** 净利润230万美元(每股0.16美元),相比去年同期净亏损220万美元(每股亏损0.16美元),实现扭亏为盈。调整后净利润340万美元(每股0.24美元),同比增长21.4%(去年同期280万美元,每股0.20美元)。 **EBITDA
2025-11-08 12:12
Barrington Research analyst Kevin Steinke maintains HireQuest (NASDAQ:HQI) with a Outperform and maintains $13 price target.
2025-08-28 19:58
HireQuest, Inc. (($HQI)) has held its Q2 earnings call. Read on for the main hi...
2025-08-13 09:25
HireQuest ( ($HQI) ) just unveiled an update. On August 12, 2025, HireQuest, In...
2025-08-13 04:41
HireQuest (NASDAQ:HQI) declares $0.06/share quarterly dividend, in line with previous. Forward yield 2.43% Payable Sept. 15; for shareholders of record Sept. 1; ex-div Sep. 1. See HQI Dividend Scoreca...
2025-08-13 04:22
HireQuest's Offer Provides Superior Value to TrueBlue's Stand-Alone ProspectsGOOSE CREEK, SC / ACCESS Newswire / May 19, 2025 / HireQuest, Inc. (NASDAQ:HQI) today issued the following statements in response to the
2025-05-19 20:54